Latest News

First patient randomised in the phase 3 NODE-301 trial evaluating etripamil

Milestone Pharmaceuticals, a clinical-stage cardiovascular company, announced that the first patient has been randomised in its phase 3 clinical study of etripamil. Etripamil is...

Features

Cybersecurity safety communications for implantable cardiac devices: Year in review

Cyber security has become a hot topic in recent years. Leslie Saxon writes in Cardiac Rhythm News about the cybersecurity risks for implantable cardiac...

Stroke – the need for interdisciplinary concepts

The link between cardiac diseases and stroke is well known and reported. Wolfram Döhner writes in Cardiac Rhythm News about the needs for interdisciplinary...

Videos

This video has been sponsored by LivaNova. Sleep apnoea is a major chronic disease that can have cardiovascular consequences. Around 40–50% of people with atrial fibrillation (AF) have obstructive sleep apnoea, rising to around 60% in patients with implantable cardiac...

Dhanunjaya Lakkireddy

Luigi Di Biase

Nassir Marrouche

(Visited 24,110 times, 16 visits today)